Form 8-K - Current report:
SEC Accession No. 0001193125-25-178950
Filing Date
2025-08-12
Accepted
2025-08-12 16:08:33
Documents
11
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eras-20250812.htm   iXBRL 8-K 42952
2 EX-99.1 eras-ex99_1.htm EX-99.1 170088
  Complete submission text file 0001193125-25-178950.txt   332007

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20250812.xsd EX-101.SCH 25793
13 EXTRACTED XBRL INSTANCE DOCUMENT eras-20250812_htm.xml XML 4879
Mailing Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 251206714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)